Literature DB >> 16118458

Animal models of renal fibrosis.

Michael Zeisberg1, Mary A Soubasakos, Raghu Kalluri.   

Abstract

Most of the present knowledge on pathomechanism of renal fibrosis is based on experimental studies with laboratory animals. Today, a variety of genetic and inducible animal models that mimic primary causes of human disease such as diabetes mellitus, glomerulonephritis, or lupus erythematodes are available. However, only few of these models progress consistently to interstitial fibrosis in the kidney involving interestitial fibrosis, tubular atrophy, and glomerulosclerosis, which are common features of renal fibrogenesis. In this chapter, the mouse models of nephrotoxic serum nephritis, COL4A3-deficiency, and unilateral urethral obstruction, which all result reliably into renal fibrosis, are described.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118458     DOI: 10.1385/1-59259-940-0:261

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  12 in total

1.  Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis.

Authors:  Dany Anglicheau; Thangamani Muthukumar; Aurélie Hummel; Ruchuang Ding; Vijay K Sharma; Darshana Dadhania; Surya V Seshan; Joseph E Schwartz; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2012-06-15       Impact factor: 4.939

2.  Animal and Human Models of Tissue Repair and Fibrosis: An Introduction.

Authors:  David Lagares; Boris Hinz
Journal:  Methods Mol Biol       Date:  2021

3.  Reactive oxygen species promote caspase-12 expression and tubular apoptosis in diabetic nephropathy.

Authors:  Marie-Luise Brezniceanu; Cara J Lau; Nicolas Godin; Isabelle Chénier; Alain Duclos; Jean Ethier; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 10.121

4.  ShenKang Injection Attenuates Renal Fibrosis by Inhibiting EMT and Regulating the Wnt/β-Catenin Pathway.

Authors:  Hui-Ting Wei; Yuan Xu; Xiao-Yang Tan; Hao-Yue Jing; Yue-Rong Ma
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-28       Impact factor: 2.650

5.  Mutations in the catalytic domain of human matrix metalloproteinase-1 (MMP-1) that allow for regulated activity through the use of Ca2+.

Authors:  Rudolph D Paladini; Ge Wei; Anirban Kundu; Qiping Zhao; Louis H Bookbinder; Gilbert A Keller; H Michael Shepard; Gregory I Frost
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

6.  Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.

Authors:  Elisabeth M Zeisberg; Scott E Potenta; Hikaru Sugimoto; Michael Zeisberg; Raghu Kalluri
Journal:  J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 10.121

7.  Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis.

Authors:  Carla Q Feitoza; Giselle M Gonçalves; Patrícia Semedo; Marcos A Cenedeze; Hélady S Pinheiro; Felipe Caetano Beraldo; Oscar Fernando Pavão dos Santos; Vicente de Paula A Teixeira; Marlene A dos Reis; Marilda Mazzali; Alvaro Pacheco-Silva; Niels O S Câmara
Journal:  Mol Med       Date:  2008-08-18       Impact factor: 6.354

8.  Renal fibrosis.

Authors:  Min Hyun Cho
Journal:  Korean J Pediatr       Date:  2010-07-31

9.  Selective Targeting of Vascular Endothelial YAP Activity Blocks EndMT and Ameliorates Unilateral Ureteral Obstruction-Induced Kidney Fibrosis.

Authors:  Yafeng Ren; Yuwei Zhang; Lu Wang; Fuqian He; Mengli Yan; Xiaoheng Liu; Yangying Ou; Qinkai Wu; Tao Bi; Shiyuan Wang; Jian Liu; Bi-Sen Ding; Li Wang; Jie Qing
Journal:  ACS Pharmacol Transl Sci       Date:  2021-04-05

Review 10.  Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease.

Authors:  Natalie Sampson; Peter Berger; Christoph Zenzmaier
Journal:  Oxid Med Cell Longev       Date:  2012-10-22       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.